SCHEMBL7904534

SCHEMBL7904534

O=S(=O)(c1ccc(F)cc1)N1CC2C(C1)C2N=C=S

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PKM P14618 5/20 0.45
MAPT P10636 2/20 0.45
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 2/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
MMP2 P08253 1/20 0.40
POLB P06746 1/20 0.39
KDM4E B2RXH2 1/20 0.39
PKLR P30613 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7904572 0.86 PKM (0.47) PKMCYP2C19KMT2AMEN1ALDH1A1
SCHEMBL7906423 0.85 CYP2C9 (0.44) PKMKMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL7903086 0.85 CYP2C9 (0.44) PKMKMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL7904340 0.82 ALDH1A1 (0.60) PKMMAPTCYP3A4CYP2C19KMT2A
SCHEMBL4636596 0.75 PKM (0.53) PKMMAPTCYP3A4CYP2C19KMT2A
SCHEMBL4635235 0.72 PKM (0.49) PKMMAPTCYP3A4CYP2C19KMT2A
SCHEMBL14153169 0.72 PKM (0.56) PKMMAPTCYP3A4CYP2C19KMT2A
SCHEMBL13007128 0.72 MEN1 (0.60) PKMMAPTCYP3A4CYP2C19KMT2A
SCHEMBL2060101 0.72 PKM (0.56) PKMMAPTCYP3A4CYP2C19KMT2A
SCHEMBL7903110 0.70 MEN1 (0.51) MAPTKMT2AMEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194438-B1 ANTITUMOR AGENTS; ANTICANCER AGENTS; FARNESYL-PROTEIN TRANSFERASE INHIBITOR PFIZER INC. 2001-02-27 US disclosed
EP-1006113-A1 Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use to inhibit abnormal cell growth Pfizer Products Inc. (US) 2000-06-07 EP disclosed